Early research (Phase 1)Study completedNCT00917813What this trial is testingAnti-HIV Monoclonal Antibody KD-247Who this might be right forHIV Infections The Chemo-Sero-Therapeutic Research Institute 27
Early research (Phase 1)Study completedNCT00119873What this trial is testingSafety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT01109940What this trial is testingSafety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing SpondylitisWho this might be right forAnkylosing Spondylitis Novartis Pharmaceuticals 39
Testing effectiveness (Phase 2)UnknownNCT04396067What this trial is testingAerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative TreatmentWho this might be right forCOVID-19 Kafrelsheikh University 360
Testing effectiveness (Phase 2)WithdrawnNCT05480657What this trial is testingSafety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cells in Adults With Brittle T1DWho this might be right forBrittle Type 1 Diabetes Mellitus Eledon Pharmaceuticals
Early research (Phase 1)Study completedNCT03961438What this trial is testingAmsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope VaccineWho this might be right forHIV-1-infection Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24
Testing effectiveness (Phase 2)Study completedNCT04524507What this trial is testingCoronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized PatientsWho this might be right forCOVID-19 University of North Carolina, Chapel Hill 56
Not applicableUnknownNCT02826811What this trial is testingRole of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BKWho this might be right forGraft Dysfunction University Hospital, Strasbourg, France 170
Early research (Phase 1)Study completedNCT02463227What this trial is testingEvaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment InterruptionWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 14
Testing effectiveness (Phase 2)Looking for participantsNCT07054931What this trial is testingCombination Vaccination and Broadly Neutralising Antibody Therapy in HIVWho this might be right forHIV University of Oxford 48
Not applicableUnknownNCT05977101What this trial is testingThe Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy SubjectsWho this might be right forSARS-CoV-2Prevention The Second Affiliated Hospital of Chongqing Medical University 72
Testing effectiveness (Phase 2)Study completedNCT01171209What this trial is testingREsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis PatientsWho this might be right forMultiple Sclerosis Melinda Magyari 10
Testing effectiveness (Phase 2)Study completedNCT02850016What this trial is testingRomidepsin Plus 3BNC117 Phase 2a StudyWho this might be right forHuman Immunodeficiency Virus (HIV) Rockefeller University 48
Testing effectiveness (Phase 2)WithdrawnNCT04144335What this trial is testingN-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIVWho this might be right forHivHIV/AIDSHIV Infections+3 more University of Minnesota
Large-scale testing (Phase 3)Study completedNCT05846568What this trial is testingStudy to Evaluate GR1801's Efficacy and SafetyWho this might be right forRabies Post-exposure Prophylaxis Genrix (Shanghai) Biopharmaceutical Co., Ltd. 1,200
Testing effectiveness (Phase 2)WithdrawnNCT03619278What this trial is testingEvaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV InfectionWho this might be right forHIV Infections Judit Pich
Large-scale testing (Phase 3)Study completedNCT02360514What this trial is testingStudy to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRSWho this might be right forInfection Green Cross Corporation 226
Early research (Phase 1)Study completedNCT01950325What this trial is testingVRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...Who this might be right forHIV-1 InfectionNeutralizing AntibodyMonoclonal Antibody+2 more National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Looking for participantsNCT05719441What this trial is testingA Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV RemissionWho this might be right forAcute HIV Infection National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT04532294What this trial is testingSafety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy ParticipantsWho this might be right forCovid19 BeiGene 18